Search
DocGo Inc
DCGOAdd to Watchlist
0.373USD
+0.003+0.81%
Market hours 10/05, 09:45（ET）
36.84MMarket Cap
LossP/E TTM
DocGo Inc (DCGO) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to DocGo Inc in the past month.
Buy
1 Strong Buy
1 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
1.900USD+414.21%
DCGO Analyst Recommendation Trends
In the current month, DCGO has received 1 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. DCGO average Analyst price target in the last month is 1.900.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
3
3
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
6
6
6
6
DCGO Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
3
0
0
28
HCA Healthcare Inc
HCA
5
10
11
1
0
27
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
12
3
0
0
25
Tenet Healthcare Corp
THC
5
14
4
0
0
23
Universal Health Services Inc
UHS
2
4
14
1
0
21
Labcorp Holdings Inc
LH
6
8
5
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
5
12
1
0
0
18
Financial Forecasting
Based on analysts' estimates, DCGO EPS is projected to reach -0.092 in FY2026Q3, following reported EPS of -0.160 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.13
-0.09
-0.06
-0.09
-0.07
Actual
-1.37
-0.15
-0.16
--
--
Surprise
-939.22%
-60.20%
-158.26%
--
--
FAQs
What is DocGo Inc's expected revenue for the next quarter?
DocGo Inc's expected revenue is 77.19M.
What is DocGo Inc's price target?
Analysts forecast that DocGo Inc's price target is USD 1.90, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.00.
How have DocGo IncDCGO's recent earnings per share performed?
The market expectation was USD -0.16, while DocGo IncDCGO's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for DocGo Inc?
Based on the ratings of DocGo Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.